Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy

NCT00571168 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

362

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Emend
DRUG: Placebo

Sponsor

Heidelberg University

Collaborators

[object Object]